alexa The Cholesterol-ceramide Connection As A Possible Link Between Diabetes And Alzheimer?s Disease
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Ian Martins
Posters: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.027
Molecular mechanisms involved with neuroendocrine diseases such as obesity and diabetes are closely linked to insulin resistance and require attention since metabolic dysfunction has also been associated with neurodegeneration. The global increase in these chronic diseases supports a role for lipids, such as ceramide and its metabolites in the pathogenesis of these diseases. The link between the ceramide and its pathogenesis of diabetes has been an important discovery that may assist with the role of ceramide in the pathogenesis of Alzheimer?s disease (AD) also referred to as Type 3 diabetes. Lipids such as cholesterol and ceramide have been connected to processing of the amyloid precursor protein with generation or regulation of beta-amyloid production that is central to the amyloid hypothesis in AD. The cholesterol-ceramide connection has been previously linked with aging and AD. Lipidomic analysis using mass spectrometry of fasting plasma from an ageing cohort (AIBL) that includes mild cognitively impaired individuals, cognitively healthy controls and AD patients at baseline have been provided in this study. The plasma lipid ceramide was elevated in AD patients and this study provides potential for early therapeutic targets that reduce ceramide levels to manage hypercholesterolemia and insulin resistance in both diabetes and AD.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version